93 related articles for article (PubMed ID: 23929905)
21. Intensity modulated radiation therapy safe, effective for prostate cancer.
Duke Med Health News; 2007 Jan; 13(1):10. PubMed ID: 17299890
[No Abstract] [Full Text] [Related]
22. Clinical stage T3 prostate cancer: the added value of three-dimensional conformal/intensity-modulated external-beam radiotherapy.
Bolla M
Eur Urol; 2008 Jun; 53(6):1104-6; discussion 1106-8. PubMed ID: 18295394
[No Abstract] [Full Text] [Related]
23. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
24. Examining attitudes of specialist physicians regarding physician assistant referrals.
Enns SM; Wynn T; Muma RD; Lary MJ
J Allied Health; 2003; 32(4):270-4. PubMed ID: 14714602
[TBL] [Abstract][Full Text] [Related]
25. Family physicians' referral decisions: results from the ASPN referral study.
Forrest CB; Nutting PA; Starfield B; von Schrader S
J Fam Pract; 2002 Mar; 51(3):215-22. PubMed ID: 11978231
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy for prostate cancer.
Elconin JH
N Engl J Med; 2007 Jan; 356(3):309-10; author reply 310-1. PubMed ID: 17240536
[No Abstract] [Full Text] [Related]
27. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
28. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.
Alicikus ZA; Yamada Y; Zhang Z; Pei X; Hunt M; Kollmeier M; Cox B; Zelefsky MJ
Cancer; 2011 Apr; 117(7):1429-37. PubMed ID: 21425143
[TBL] [Abstract][Full Text] [Related]
29. Medical memo: high-dose radiotherapy for prostate cancer.
Harv Mens Health Watch; 2007 Apr; 11(9):6. PubMed ID: 17441270
[No Abstract] [Full Text] [Related]
30. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
[TBL] [Abstract][Full Text] [Related]
31. IMRT and molecular biological approaches in radiotherapy for prostate cancer.
Bristow RG
Eur J Cancer; 2009 Sep; 45 Suppl 1():429-30. PubMed ID: 19775659
[No Abstract] [Full Text] [Related]
32. [High dose for prostate irradiation with image guided radiotherapy: contribution of intensity modulation arctherapy].
Jouyaux F; De Crevoisier R; Manens JP; Bellec J; Cazoulat G; Haigron P; Chira C; Le Prisé E; Lafond C
Cancer Radiother; 2010 Dec; 14(8):679-89. PubMed ID: 20570202
[TBL] [Abstract][Full Text] [Related]
33. Rotational radiotherapy for prostate cancer in clinical practice.
Aznar MC; Petersen PM; Logadottir A; Lindberg H; Korreman SS; Kjær-Kristoffersen F; Engelholm SA
Radiother Oncol; 2010 Dec; 97(3):480-4. PubMed ID: 20970215
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of intensity-modulated radiotherapy for prostate cancer using an empty bladder protocol.
Tuan JK; Ha TC; Ong WS; Siow TR; Tham IW; Ng WL; Wang ML; Chua ET; Tan TW
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):e137-9. PubMed ID: 22795829
[No Abstract] [Full Text] [Related]
35. Radiation management of prostate cancer.
Glicksman AS
Med Health R I; 2006 Feb; 89(2):74-5. PubMed ID: 16583666
[No Abstract] [Full Text] [Related]
36. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
37. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
Albertini F; Lomax AJ; Hug EB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
[No Abstract] [Full Text] [Related]
38. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.
Aizer AA; Anderson NS; Oh SC; Yu JB; McKeon AM; Decker RH; Peschel RE
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):379-84. PubMed ID: 20452135
[TBL] [Abstract][Full Text] [Related]
39. A practical approach to diode based in vivo dosimetry for intensity modulated radiotherapy.
Kadesjö N; Nyholm T; Olofsson J
Radiother Oncol; 2011 Mar; 98(3):378-81. PubMed ID: 21295879
[TBL] [Abstract][Full Text] [Related]
40. [Prostate cancer].
Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
